Non-small cell lung cancer (NSCLC): Paradoxically, higher stromal FAP levels have been linked to improved prognosis, reinforcing the need for tumor-specific interpretation in clinical settings [121]. The gene discussed is FAP; the disease is non-small cell lung carcinoma.